Broncho-munal, capsules 7 mg 30 pcs

ATX code: L03AX.

Pharmacotherapeutic group: immunostimulant.

Nosological classification: ICD-10

Pharmacological properties

Pharmacodynamics
Broncho-Munal® has an immune stimulating effect by strengthening the immunity against bacteria and viruses, respiratory tract infections.
After taking the capsule the bacterial lysate accumulates in the peyer’s plaques of the gastrointestinal mucosa, in particular those located in the small intestine. Antigen-presenting cells in the peyer’s plaques are activated by the bacterial lysate and subsequently stimulate other cell types (B-lymphocytes) responsible for specific immunity.

This leads to an increase in circulating B-lymphocytes, which leads to increased production of polyclonal antibodies, especially serum IgG and IgA, secreted by the respiratory mucosa and salivary glands.

The drug also affects non-specific immunity by stimulating leukocytes, characterized by increase of myeloid and lymphoid cells number and selective increase of receptors expression on their surface.

Clinically Broncho-Munal® reduces the frequency of acute respiratory tract infections, reduces the duration of their course, reduces the likelihood of exacerbations of chronic bronchitis, as well as increases the body’s resistance to infections of the respiratory system. It also reduces the need to use other medicines, especially antibiotics.

Indications

Active ingredient

Composition

How to take, the dosage

Interaction

Special Instructions

Synopsis

Contraindications

Side effects

Overdose

Similarities